Arild Nesbakken

Arild Nesbakken is a Clinical Associate Professor at the Faculty of Medicine, University of Oslo, affiliated with the Department of Surgery at Oslo University Hospital (OUS). His research focuses on colorectal cancer, molecular biomarkers, tumor heterogeneity, and geriatric oncology, with a strong emphasis on translational studies linking genomic features to clinical outcomes.

Recent publications highlight his work in transcriptomic subtyping, pharmacogenomics, and imaging techniques for rectal cancer staging. He collaborates extensively with international research groups, including computational oncology teams and molecular pathology experts, contributing to studies on consensus molecular subtypes, immune microenvironment, and organoid modeling for personalized treatment strategies.

His 15 most recent articles (2022–2025) span topics such as ex vivo tumor heterogeneity, MRI optimization, serum biomarkers, macrophage-T cell interactions, and geriatric assessment tools. These studies reflect his commitment to integrating multi-omics data with clinical decision-making to improve colorectal cancer outcomes.

Arild Nesbakken's work is supported by collaborations with institutions like the Centre for Cancer Biomedicine (OUS), Ragnhild Lothe's cancer prevention division, and Anita Sveen's molecular genetics group. He actively participates in international audits and GOSAFE studies, addressing disparities in cancer care and refining prognostic models.